Diffusion kurtosis imaging in patients with locally advanced rectal cancer: current status and future perspectives.
Rectal cancer
diffusion kurtosis imaging
diffusion-weighted imaging
magnetic resonance imaging
preoperative chemoradiotherapy
retrospective review
Journal
The Journal of international medical research
ISSN: 1473-2300
Titre abrégé: J Int Med Res
Pays: England
ID NLM: 0346411
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
pubmed:
30
4
2019
medline:
18
12
2019
entrez:
30
4
2019
Statut:
ppublish
Résumé
Morphological magnetic resonance imaging is currently the best imaging technique for local staging in patients with rectal cancer. However, morphological sequences have some limitations, especially after preoperative chemoradiotherapy (pCRT). Diffusion-weighted imaging has been applied to rectal cancer for detection of lesions, characterization of tissue, and evaluation of the response to therapy. In 2005, a non-Gaussian diffusion model called diffusion kurtosis imaging (DKI) was suggested. Several electronic databases were evaluated in the present review. The search included articles published from January 2000 to May 2018. The references of all articles were also evaluated. All titles and abstracts were assessed, and only the studies of DKI in patients with rectal cancer were retained. We identified 35 potentially relevant references through the electronic search. According to the inclusion and exclusion criteria, we retained five clinical studies that met the inclusion criteria. DKI is a useful tool for assessment of tumor aggressiveness, the nodal status, and the risk of early metastases as well as prediction of the response to pCRT. The results of DKI should be considered in treatment decision-making during the work-up of patients with rectal cancer.
Identifiants
pubmed: 31032670
doi: 10.1177/0300060519827168
pmc: PMC6567719
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2351-2360Références
Radiology. 2010 Mar;254(3):876-81
pubmed: 20089718
NMR Biomed. 2010 Aug;23(7):698-710
pubmed: 20632416
Radiology. 2011 Sep;260(3):734-43
pubmed: 21673229
Radiology. 2011 Sep;260(3):771-80
pubmed: 21846762
Ann Surg Oncol. 2012 Apr;19(4):1213-21
pubmed: 21935746
Radiology. 2012 May;263(2):492-501
pubmed: 22403168
Radiology. 2012 Jul;264(1):126-35
pubmed: 22550312
Magn Reson Imaging. 2012 Dec;30(10):1534-40
pubmed: 22819175
J Dig Dis. 2014 Apr;15(4):188-94
pubmed: 24373561
Magn Reson Imaging. 2014 Jun;32(5):421-7
pubmed: 24602826
Eur Radiol. 2014 Jun;24(6):1197-203
pubmed: 24658871
Ann Surg Oncol. 2015 Mar;22(3):916-23
pubmed: 25190129
Radiology. 2015 Oct;277(1):46-55
pubmed: 25938679
Biomed Res Int. 2015;2015:514740
pubmed: 26413528
PLoS One. 2015 Nov 13;10(11):e0142876
pubmed: 26566221
J Magn Reson Imaging. 2016 Jul;44(1):221-9
pubmed: 26715111
Eur Radiol. 2017 May;27(5):1848-1857
pubmed: 27631106
MAGMA. 2017 Apr;30(2):113-120
pubmed: 27670762
Radiology. 2017 Jul;284(1):66-76
pubmed: 27929929
Oncotarget. 2017 Jan 31;8(5):8143-8153
pubmed: 28042958
Colorectal Dis. 2018 Feb;20(2):116-125
pubmed: 28772347
Radiol Oncol. 2017 Aug 16;51(3):252-262
pubmed: 28959161
Eur Radiol. 2018 Apr;28(4):1485-1494
pubmed: 29063250
Oncotarget. 2017 Apr 27;8(43):75597-75606
pubmed: 29088894
Med Oncol. 2017 Nov 18;34(12):198
pubmed: 29151142
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Anticancer Res. 2018 Feb;38(2):969-978
pubmed: 29374729
Clin Transl Radiat Oncol. 2017 Mar 23;3:9-15
pubmed: 29658007
Insights Imaging. 2018 Aug;9(4):405-412
pubmed: 29675627
Abdom Radiol (NY). 2018 Oct 25;:null
pubmed: 30361867
Cancer. 1994 Jun 1;73(11):2680-6
pubmed: 8194005